Loading insider details...
Beta
Latest Form 4 (Oct 1, 2026): Exercise/Conversion of 921 CNSY shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 1, 2026 | CERENOME, INC. (CNSY) | Exercise/Conversion | 921 | n/a |
| Jul 1, 2026 | PLUS THERAPEUTICS, INC. (PSTV) | Exercise/Conversion | 922 | n/a |
| May 18, 2026 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 3,686 | n/a |
| Dec 11, 2025 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Aug 15, 2025 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 297,794 | n/a |
| Feb 20, 2025 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 40,122 | n/a |
| Dec 16, 2024 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Sep 12, 2024 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 3,650 | n/a |
| Jun 7, 2024 | LUMOS PHARMA, INC. | Grant/Award | 3,328 | n/a |
| Feb 26, 2024 | PLUS THERAPEUTICS, INC. (PSTV) | Grant/Award | 2,250 | n/a |